-
Synmosa Acquires Over 90% Majority Stake in Seven Star Pharmaceutical
Date:2016.11.28 Inthewakeofacollaborationbetwee...
more → -
Synmosa Biopharma Inks NT$210 million Licensing Agreement for Budesonide
Date:2016.08.04 SynmosaBiopharma(TPEx:4114)toda...
more → -
Synmosa's Posts Highest Single-Quarter Earnings Ever, EPS Hits NT$1.35
Date:2016.05.09 SynmosaBiopharma(TPEx:4114)rece...
more → -
Synmosa Signs NT$420 million Deal with Hemony Pharma
Date:2016.05.03 Inlessthansixmonths,SynmosaBiop...
more → -
Synmosa Collaborates with InnoPharmax to Branch Out into Production of API
Date:2016.03.24 SynmosaBiopharma(TPEx:4114)toda...
more → -
Synmosa Group Achieves Rapid Growth, Posts Revenue of Over NT$200 Million in a Single Month
Date:2016.02.15 SynmosaBiopharma(TPEx:4114)toda...
more → -
Synmosa Group Subsidiary Ningbo Youhe Awarded GSP Certification
Date:2016.01.06 SynmosaBiopharma(TPEx:4114)toda...
more →
Honesty • Credibility • Reliability • Innovation
The leading Specialty Pharmaceutical Corporation in Asia.
